Clinical Trial of SARS-CoV-2 mRNA Vaccine in Chinese People

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
Phase Ⅱ Clinical Trial to Evaluate the Safety and Immunogenicity of the New Coronavirus mRNA Vaccine (LVRNA009) in Chinese People Aged 18 59 Years
Epistemonikos ID: 067f3caea76f6bb17e6026dd2f1d59fe9f4e39e0
First added on: Apr 30, 2022